The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Roche; SERVIER; Takeda
Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international study.
 
Robert J. Kreitman
Patents, Royalties, Other Intellectual Property - NIH/NCI
 
Claire Dearden
Research Funding - MedImmune
Other Relationship - Gilead Sciences; Infinity Pharmaceuticals; Janssen; MedImmune; Roche; Sanofi/Aventis
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Julio Delgado
Honoraria - MedImmune
Other Relationship - Abbvie; Gilead Sciences; Janssen; Roche
 
Tadeusz Robak
Research Funding - AstraZeneca
 
Phillipp D. Le Coutre
Honoraria - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Bjorn T. Gjertsen
Leadership - Alden Cancer Therapy II; Kinn Therapeutics
Stock and Other Ownership Interests - Alden Cancer Therapy II; Kinn Therapeutics
Consulting or Advisory Role - BerGenBio; Novartis; Seagen
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Alden Cancer Therapy II patent application in relation to CryoIT trial.
Travel, Accommodations, Expenses - Novartis; Seagen
 
Xavier Troussard
No Relationships to Disclose
 
Guiseppe Saglio
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Novartis; Pfizer
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Amgen; Amphivena; argenx; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Cellectis; Celltrion; Clovis Oncology; CTI; Eisai; Genentech/Roche; Genoptix; Immune Pharmaceuticals; Janssen; Jazz Pharmaceuticals; MedImmune; Novartis; Orsenix; Pfizer; Sandoz; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); CTI (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals
 
Lionel Karlin
No Relationships to Disclose
 
Douglas Edward Gladstone
No Relationships to Disclose
 
Kemal Balic
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Nathan Standifer
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Peng He
Employment - Medimmune
Stock and Other Ownership Interests - AstraZeneca
 
Shannon Marshall
No Relationships to Disclose
 
Wyndham Hopkins Wilson
No Relationships to Disclose
 
Ira Pastan
No Relationships to Disclose
 
Nai-Shun Yao
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Francis J. Giles
Consulting or Advisory Role - Novartis
Research Funding - Novartis